{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:30:45Z","timestamp":1794475845851,"version":"4.9.1"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ygyno.2026.04.004","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T19:51:58Z","timestamp":1777319518000},"page":"15-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Endometrial cancer: A Society of Gynecologic Oncology evidence-based review and recommendations: Part I"],"prefix":"10.1016","volume":"209","author":[{"given":"Renata","family":"Urban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kemi","family":"Doll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"DeLair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramez","family":"Eskander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Westin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaranta","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitfield","family":"Growdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Musa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2026.04.004_bb0060","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/aje\/kwae178","article-title":"Trends in endometrial cancer incidence in the United States by race\/ethnicity and age of onset from 2000 to 2019","volume":"194","author":"Rodriguez","year":"2025","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ygyno.2026.04.004_bb0005","author":"CDC"},{"issue":"4","key":"10.1016\/j.ygyno.2026.04.004_bb0556","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1097\/01.AOG.0000462977.61229.de","volume":"125","year":"2015","journal-title":"Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.ygyno.2026.04.004_bb0010","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1097\/01.AOG.0000450757.18294.cf","article-title":"Tamoxifen and uterine cancer","volume":"123","author":"Committee Opinion No. 601","year":"2014","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.04.004_bb0015","doi-asserted-by":"crossref","first-page":"24884","DOI":"10.1038\/s41598-024-76896-8","article-title":"Association of endometrial cancer risk with hypertension- an updated meta-analysis of observational studies","volume":"14","author":"Drab","year":"2024","journal-title":"Sci. Rep."},{"issue":"5 Pt 1","key":"10.1016\/j.ygyno.2026.04.004_bb0020","first-page":"941","article-title":"Development of endometrial cancer after radiation treatment for cervical carcinoma","volume":"101","author":"Pothuri","year":"2003","journal-title":"Obstet. Gynecol."},{"issue":"21","key":"10.1016\/j.ygyno.2026.04.004_bb0557","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMra1514010","article-title":"Endometrial Cancer","volume":"383","author":"Lu","year":"2020","journal-title":"The New England journal of medicine"},{"issue":"5","key":"10.1016\/j.ygyno.2026.04.004_bb0025","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1053\/j.seminoncol.2007.07.009","article-title":"Cowden syndrome","volume":"34","author":"Gustafson","year":"2007","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ygyno.2026.04.004_bb0030","article-title":"Endometrial cancer risk among germline BRCA1\/2 pathogenic variant carriers: review of our current understanding and next steps","volume":"7","author":"Sorouri","year":"2023","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.ygyno.2026.04.004_bb0558","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ygyno.2024.07.687","article-title":"Incidence of endometrial cancer in BRCA mutation carriers","volume":"189","author":"Kotsopoulos","year":"2024","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.04.004_bb0035","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1186\/s12889-019-7262-7","article-title":"Prognostic factors for rural endometrial cancer patients in a population-based cohort","volume":"19","author":"Blackburn","year":"2019","journal-title":"BMC Public Health"},{"issue":"14","key":"10.1016\/j.ygyno.2026.04.004_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19148613","article-title":"The geographic context of racial disparities in aggressive endometrial cancer subtypes: integrating social and environmental aspects to discern biological outcomes","volume":"19","author":"Miller","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"Pt 1","key":"10.1016\/j.ygyno.2026.04.004_bb0045","article-title":"Hair relaxer use and risk of uterine cancer in the black women\u2019s health study","volume":"239","author":"Bertrand","year":"2023","journal-title":"Environ. Res."},{"issue":"22","key":"10.1016\/j.ygyno.2026.04.004_bb0050","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1200\/JCO.19.00151","article-title":"Hysterectomy-corrected uterine corpus cancer incidence trends and differences in relative survival reveal racial disparities and rising rates of nonendometrioid cancers","volume":"37","author":"Clarke","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.04.004_bb0055","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ygyno.2022.02.004","article-title":"Pathologic characteristics, patterns of care, and outcomes of Asian-Americans and pacific islanders with uterine cancer","volume":"165","author":"Huang","year":"2022","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2026.04.004_bb0065","first-page":"421","article-title":"Risk factors for endometrial cancer in black women","volume":"34","author":"Sponholtz","year":"2023","journal-title":"Cancer Causes Control"},{"issue":"9","key":"10.1016\/j.ygyno.2026.04.004_bb0070","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.32296","article-title":"Reproductive factors and endometrial cancer risk among women","volume":"6","author":"Katagiri","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ygyno.2026.04.004_bb0075","article-title":"Disparities in cancer-specific and overall survival in black women with endometrial cancer: a Medicare-SEER study","volume":"40","author":"Saris","year":"2022","journal-title":"Gynecol. Oncol. Rep."},{"key":"10.1016\/j.ygyno.2026.04.004_bb0080","series-title":"Available from: Revisions to OMB's Statistical Policy Directive No. 15: Standards for Maintaining, Collecting, and Presenting Federal Data on Race and Ethnicity","author":"Register","year":"2024"},{"issue":"9","key":"10.1016\/j.ygyno.2026.04.004_bb0085","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/jamainternmed.2018.2820","article-title":"Association of endometrial cancer risk with postmenopausal bleeding in women: a systematic review and meta-analysis","volume":"178","author":"Clarke","year":"2018","journal-title":"JAMA Intern. Med."},{"issue":"2","key":"10.1016\/j.ygyno.2026.04.004_bb0090","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/GME.0000000000000736","article-title":"Duration of the menopausal transition is longer in women with young age at onset: the multiethnic study of women\u2019s health across the nation","volume":"24","author":"Paramsothy","year":"2017","journal-title":"Menopause"},{"issue":"10","key":"10.1016\/j.ygyno.2026.04.004_bb0095","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/GME.0000000000002411","article-title":"Public awareness and provider counseling regarding postmenopausal bleeding as a symptom of endometrial cancer","volume":"31","author":"Wise","year":"2024","journal-title":"Menopause"},{"issue":"6","key":"10.1016\/j.ygyno.2026.04.004_bb0100","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ajog.2018.09.040","article-title":"Role of bleeding recognition and evaluation in Black-White disparities in endometrial cancer","volume":"219","author":"Doll","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.ygyno.2026.04.004_bb0105","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1097\/AOG.0000000000002631","article-title":"The role of transvaginal ultrasonography in evaluating the endometrium of women with postmenopausal bleeding","volume":"131","author":"ACOG Committee Opinion No. 734","year":"2018","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.ygyno.2026.04.004_bb0110","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ajog.2020.03.032","article-title":"Risk assessment of endometrial cancer and endometrial intraepithelial neoplasia in women with abnormal bleeding and implications for clinical management algorithms","volume":"223","author":"Clarke","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"8","key":"10.1016\/j.ygyno.2026.04.004_bb0115","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/jamaoncol.2021.1700","article-title":"Estimated performance of transvaginal ultrasonography for evaluation of postmenopausal bleeding in a simulated cohort of black and white women in the US","volume":"7","author":"Doll","year":"2021","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ygyno.2026.04.004_bb0120","article-title":"Impact of abnormal uterine bleeding care in premenopausal patients prior to endometrial malignancy diagnosis","volume":"50","author":"Grubman","year":"2023","journal-title":"Gynecol. Oncol. Rep."},{"issue":"1","key":"10.1016\/j.ygyno.2026.04.004_bb0125","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/jnci\/djae210","article-title":"Understanding risk factors for endometrial cancer in young women","volume":"117","author":"Peeri","year":"2025","journal-title":"J. Natl. Cancer Inst."},{"issue":"7","key":"10.1016\/j.ygyno.2026.04.004_bb0130","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1200\/JCO.2010.31.2124","article-title":"Influence of gynecologic oncologists on the survival of patients with endometrial cancer","volume":"29","author":"Chan","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2026.04.004_bb0135","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ygyno.2021.08.013","article-title":"A look at the gynecologic oncologist workforce - are we meeting patient demand?","volume":"163","author":"Ackroyd","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2026.04.004_bb0140","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ygyno.2019.03.244","article-title":"Time to surgery and its impact on survival in patients with endometrial cancer: a national cancer database study","volume":"153","author":"AlHilli","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.04.004_bb0145","first-page":"e1","article-title":"Predictive value of serum human epididymis protein 4 and cancer antigen 125 concentrations in endometrial carcinoma","volume":"209(2):142","author":"Saarelainen","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"11","key":"10.1016\/j.ygyno.2026.04.004_bb0150","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/aogs.12235","article-title":"HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET)","volume":"92","author":"Antonsen","year":"2013","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"2","key":"10.1016\/j.ygyno.2026.04.004_bb0155","first-page":"947","article-title":"Influence of delayed diagnosis on established prognostic factors in endometrial cancer","volume":"16","author":"Obermair","year":"1996","journal-title":"Anticancer Res."},{"issue":"5","key":"10.1016\/j.ygyno.2026.04.004_bb0160","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1007\/s11701-023-01609-8","article-title":"Morbid obesity increases the failure rate of sentinel lymph node mapping for endometrial carcinoma","volume":"17","author":"Johnson","year":"2023","journal-title":"J. Robot. Surg."},{"issue":"5","key":"10.1016\/j.ygyno.2026.04.004_bb0165","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ajog.2016.11.1033","article-title":"Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis","volume":"216","author":"Bodurtha Smith","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2026.04.004_bb0170","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ygyno.2014.05.018","article-title":"Endometrial cancer: a review and current management strategies: part I","volume":"134","author":"Group SGOCPECW","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2026.04.004_bb0175","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bpobgyn.2014.04.007","article-title":"Imaging in endometrial cancer","volume":"28","author":"Epstein","year":"2014","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"10333","key":"10.1016\/j.ygyno.2026.04.004_bb0180","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0140-6736(22)00323-3","article-title":"Endometrial cancer","volume":"399","author":"Crosbie","year":"2022","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ygyno.2026.04.004_bb0185","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41379-018-0158-8","article-title":"Targeted next-generation sequencing of endometrial cancer and matched circulating tumor DNA: identification of plasma-based, tumor-associated mutations in early stage patients","volume":"32","author":"Bolivar","year":"2019","journal-title":"Mod. Pathol."},{"issue":"10","key":"10.1016\/j.ygyno.2026.04.004_bb0190","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1007\/s00261-017-1179-3","article-title":"Fertility-sparing for young patients with gynecologic cancer: how MRI can guide patient selection prior to conservative management","volume":"42","author":"McEvoy","year":"2017","journal-title":"Abdom. Radiol. (NY)"},{"issue":"2","key":"10.1016\/j.ygyno.2026.04.004_bb0195","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/ijgc-2022-004047","article-title":"ESGO\/ESHRE\/ESGE guidelines for the fertility-sparing treatment of patients with endometrial carcinoma","volume":"33","author":"Rodolakis","year":"2023","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"8","key":"10.1016\/j.ygyno.2026.04.004_bb0205","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(10)70143-1","article-title":"Safety of laparoscopy versus laparotomy in early-stage endometrial cancer: a randomised trial","volume":"11","author":"Mourits","year":"2010","journal-title":"Lancet Oncol."},{"issue":"32","key":"10.1016\/j.ygyno.2026.04.004_bb0210","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1200\/JCO.2009.22.3248","article-title":"Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: gynecologic oncology group study LAP2","volume":"27","author":"Walker","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.ygyno.2026.04.004_bb0385","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1001\/jama.2017.2068","article-title":"Effect of total laparoscopic hysterectomy vs total abdominal hysterectomy on disease-free survival among women with stage i endometrial cancer: a randomized clinical trial","volume":"317","author":"Janda","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2026.04.004_bb0215","doi-asserted-by":"crossref","first-page":"1219371","DOI":"10.3389\/fonc.2023.1219371","article-title":"Robot-assisted versus conventional laparoscopic surgery for endometrial cancer: long-term comparison of outcomes","volume":"13","author":"Eoh","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ygyno.2026.04.004_bb0220","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ygyno.2023.04.026","article-title":"Survival outcomes of robotic-assisted laparoscopy versus conventional laparoscopy and laparotomy for endometrial cancer: a systematic review and meta-analysis","volume":"174","author":"Fu","year":"2023","journal-title":"Gynecol. Oncol."},{"issue":"10","key":"10.1016\/j.ygyno.2026.04.004_bb0225","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1200\/JCO.2015.65.3212","article-title":"Comparative effectiveness of minimally invasive hysterectomy for endometrial cancer","volume":"34","author":"Wright","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2026.04.004_bb0230","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ygyno.2018.04.558","article-title":"Prospective cohort study comparing quality of life and sexual health outcomes between women undergoing robotic, laparoscopic and open surgery for endometrial cancer","volume":"149","author":"Ferguson","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.04.004_bb0235","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/AOG.0000000000004995","article-title":"Minimally invasive compared with open surgery in high-risk endometrial cancer: a systematic review and meta-analysis","volume":"141","author":"Dinoi","year":"2023","journal-title":"Obstet. Gynecol."},{"issue":"8 Suppl","key":"10.1016\/j.ygyno.2026.04.004_bb0240","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8","article-title":"Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study","volume":"60","author":"Creasman","year":"1987","journal-title":"Cancer"},{"issue":"23","key":"10.1016\/j.ygyno.2026.04.004_bb0245","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/jnci\/djn397","article-title":"Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial","volume":"100","author":"Benedetti Panici","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"issue":"9658","key":"10.1016\/j.ygyno.2026.04.004_bb0250","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(08)61766-3","article-title":"Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study","volume":"373","author":"Kitchener","year":"2009","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ygyno.2026.04.004_bb0255","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/ijgc-2023-005157","article-title":"Establishing guidelines for sentinel lymph node ultrastaging in endometrial cancer","volume":"34","author":"Chiang","year":"2024","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2026.04.004_bb0265","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ygyno.2012.06.035","article-title":"Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer","volume":"127","author":"Dowdy","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.04.004_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10010120","article-title":"Lymphedema and post-operative complications after sentinel lymph node biopsy versus lymphadenectomy in endometrial carcinomas-a systematic review and meta-analysis","volume":"10","author":"Helgers","year":"2020","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.ygyno.2026.04.004_bb0275","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ygyno.2012.02.021","article-title":"The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes","volume":"125","author":"Barlin","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2026.04.004_bb0280","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S1470-2045(17)30068-2","article-title":"A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study","volume":"18","author":"Rossi","year":"2017","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2026.04.004_bb0285","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ygyno.2017.05.016","article-title":"A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer","volume":"146","author":"Soliman","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2026.04.004_bb0290","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ajog.2021.05.034","article-title":"Sentinel lymph node biopsy in high-grade endometrial cancer: a systematic review and meta-analysis of performance characteristics","volume":"225","author":"Marchocki","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.ygyno.2026.04.004_bb0295","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ygyno.2017.09.030","article-title":"Comparison of a sentinel lymph node mapping algorithm and comprehensive lymphadenectomy in the detection of stage IIIC endometrial carcinoma at higher risk for nodal disease","volume":"147","author":"Ducie","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2026.04.004_bb0300","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ygyno.2018.08.022","article-title":"Multicenter study comparing oncologic outcomes between two nodal assessment methods in patients with deeply invasive endometrioid endometrial carcinoma: a sentinel lymph node algorithm versus a comprehensive pelvic and paraaortic lymphadenectomy","volume":"151","author":"Schlappe","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2026.04.004_bb0305","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1067\/mob.2000.107335","article-title":"Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary?","volume":"182","author":"Mariani","year":"2000","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2026.04.004_bb0310","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2016.00031","article-title":"A delay from diagnosis to treatment is associated with a decreased overall survival for patients with endometrial cancer","volume":"6","author":"Dolly","year":"2016","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2026.04.004_bb0315","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ygyno.2021.12.001","article-title":"Association of gynecologic oncology versus medical oncology specialty with survival, utilization, and spending for treatment of gynecologic cancers","volume":"164","author":"Ko","year":"2022","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2026.04.004_bb0320","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/ijgc-2023-005194","article-title":"Molecular and pathologic data to guide selection of patients with endometrioid endometrial cancer for ovarian preservation","volume":"34","author":"Manning-Geist","year":"2024","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"19","key":"10.1016\/j.ygyno.2026.04.004_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13194764","article-title":"HE4 as a biomarker for endometrial cancer","volume":"13","author":"Behrouzi","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ygyno.2026.04.004_bb0330","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1127683","article-title":"Updates in gynecologic care for individuals with lynch syndrome","volume":"13","author":"Underkofler","year":"2023","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2026.04.004_bb0340","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S1470-2045(10)70145-5","article-title":"Quality of life after total laparoscopic hysterectomy versus total abdominal hysterectomy for stage i endometrial cancer (LACE): a randomised trial","volume":"11","author":"Janda","year":"2010","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2026.04.004_bb0345","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ajog.2007.08.075","article-title":"Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths","volume":"198","author":"Ueda","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.ygyno.2026.04.004_bb0350","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ajog.2021.04.254","article-title":"Primary cytoreductive surgery for advanced stage endometrial cancer: a systematic review and meta-analysis","volume":"225","author":"Albright","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2026.04.004_bb0355","article-title":"Neoadjuvant chemotherapy for advanced stage endometrial cancer: a systematic review","volume":"38","author":"Huang","year":"2021","journal-title":"Gynecol. Oncol. Rep."},{"issue":"12","key":"10.1016\/j.ygyno.2026.04.004_bb0360","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.28612","article-title":"Association of neoadjuvant chemotherapy with overall survival in women with metastatic endometrial cancer","volume":"3","author":"Tobias","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"3","key":"10.1016\/j.ygyno.2026.04.004_bb0365","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ygyno.2021.06.016","article-title":"Use and outcomes of neoadjuvant chemotherapy for metastatic uterine cancer","volume":"162","author":"Wright","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.04.004_bb0380","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/IGC.0000000000000321","article-title":"Neoadjuvant chemotherapy versus primary cytoreductive surgery for stage IV uterine serous carcinoma","volume":"25","author":"Wilkinson-Ryan","year":"2015","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2026.04.004_bb0559","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ygyno.2021.09.006","article-title":"Patterns of care and outcomes of radiotherapy or hormone therapy in patients with medically inoperable endometrial adenocarcinoma","volume":"163","author":"Reshko","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.04.004_bb0560","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejca.2016.07.005","article-title":"Ottevanger PB; European Organisation for Research and Treatment of Cancer, Gynaecological Cancer Group (EORTC-GCG). Systemic review: Radiation therapy alone in medical non-operable endometrial carcinoma","volume":"65","author":"van der Steen-Banasik","year":"2016","journal-title":"Eur J Cancer"},{"issue":"7447","key":"10.1016\/j.ygyno.2026.04.004_bb0390","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Cancer Genome Atlas Research N","year":"2013","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ygyno.2026.04.004_bb0395","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/bjc.2015.190","article-title":"A clinically applicable molecular-based classification for endometrial cancers","volume":"113","author":"Talhouk","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2026.04.004_bb0400","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cncr.30496","article-title":"Confirmation of ProMisE: a simple, genomics-based clinical classifier for endometrial cancer","volume":"123","author":"Talhouk","year":"2017","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2026.04.004_bb0405","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/path.4947","article-title":"The genetic landscape of endometrial clear cell carcinomas","volume":"243","author":"DeLair","year":"2017","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.04.004_bb0410","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2020.04.043","article-title":"Molecular subtypes of clear cell carcinoma of the endometrium: opportunities for prognostic and predictive stratification","volume":"158","author":"Kim","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.04.004_bb0415","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1038\/s41467-019-12985-x","article-title":"Clinically relevant molecular subtypes and genomic alteration-independent differentiation in gynecologic carcinosarcoma","volume":"10","author":"Gotoh","year":"2019","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.ygyno.2026.04.004_bb0420","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ccell.2017.02.010","article-title":"Integrated molecular characterization of uterine carcinosarcoma","volume":"31","author":"Cherniack","year":"2017","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.ygyno.2026.04.004_bb0430","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/path.5373","article-title":"Clinicopathological and molecular characterisation of \u2018multiple-classifier\u2019 endometrial carcinomas","volume":"250","author":"Leon-Castillo","year":"2020","journal-title":"J. Pathol."},{"issue":"3","key":"10.1016\/j.ygyno.2026.04.004_bb0425","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/path.5372","article-title":"Interpretation of somatic POLE mutations in endometrial carcinoma","volume":"250","author":"Leon-Castillo","year":"2020","journal-title":"J. Pathol."},{"issue":"5","key":"10.1016\/j.ygyno.2026.04.004_bb0435","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/PAS.0000000000001461","article-title":"Endometrial carcinomas with a \u201cserous\u201d component in young women are enriched for DNA mismatch repair deficiency, lynch syndrome, and POLE exonuclease domain mutations","volume":"44","author":"Conlon","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"issue":"2","key":"10.1016\/j.ygyno.2026.04.004_bb0440","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"1","key":"10.1016\/j.ygyno.2026.04.004_bb0445","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/ijgc-2023-004981","article-title":"FIGO 2023 endometrial cancer staging: too much, too soon?","volume":"34","author":"McCluggage","year":"2024","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2026.04.004_bb0450","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.35596","article-title":"Challenges in implementation of molecular classification in early stage endometrial cancer-An NRG Oncology cooperative group mixed-methods study","volume":"131","author":"Wilson","year":"2025","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2026.04.004_bb0455","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ygyno.2022.06.027","article-title":"Microcystic elongated and fragmented (MELF) pattern of invasion: molecular features and prognostic significance in the PORTEC-1 and -2 trials","volume":"166","author":"van den Heerik","year":"2022","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2026.04.004_bb0460","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a gynecologic oncology group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol. Oncol."},{"issue":"9213","key":"10.1016\/j.ygyno.2026.04.004_bb0465","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC study group. Post operative radiation therapy in endometrial carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"issue":"9717","key":"10.1016\/j.ygyno.2026.04.004_bb0470","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"issue":"27","key":"10.1016\/j.ygyno.2026.04.004_bb0475","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1200\/JCO.23.00062","article-title":"Molecular classification predicts response to radiotherapy in the randomized PORTEC-1 and PORTEC-2 trials for early-stage endometrioid endometrial cancer","volume":"41","author":"Horeweg","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.04.004_bb0480","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1470-2045(25)00612-6","article-title":"Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial","volume":"27","author":"van den Heerik","year":"2026","journal-title":"Lancet Oncol."},{"issue":"16_suppl","key":"10.1016\/j.ygyno.2026.04.004_bb0485","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2023.41.16_suppl.TPS5632","article-title":"CCTG EN10: A phase II study of tailored adjuvant therapy in POLE\u2212mutated and p53-wildtype\/NSMP early-stage endometrial cancer (EC)&#x2014;RAINBO BLUE and TAPER","volume":"41","author":"McAlpine","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"21","key":"10.1016\/j.ygyno.2026.04.004_bb0490","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1200\/JCO.18.01575","article-title":"Phase III trial: adjuvant pelvic radiation therapy versus vaginal brachytherapy plus paclitaxel\/carboplatin in high-intermediate and high-risk early stage endometrial cancer","volume":"37","author":"Randall","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2026.04.004_bb0495","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1470-2045(18)30079-2","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial","volume":"19","author":"de Boer","year":"2018","journal-title":"Lancet Oncol."},{"issue":"24","key":"10.1016\/j.ygyno.2026.04.004_bb0505","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1056\/NEJMoa1813181","article-title":"Adjuvant chemotherapy plus radiation for locally advanced endometrial cancer","volume":"380","author":"Matei","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"29","key":"10.1016\/j.ygyno.2026.04.004_bb0510","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1200\/JCO.20.00549","article-title":"Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy","volume":"38","author":"Leon-Castillo","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2026.04.004_bb0515","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/IGC.0000000000000635","article-title":"An assessment of prognostic factors, adjuvant treatment, and outcomes of stage IA polyp-limited versus endometrium-limited type II endometrial carcinoma","volume":"26","author":"Liang","year":"2016","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"8","key":"10.1016\/j.ygyno.2026.04.004_bb0520","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1136\/ijgc-2020-001379","article-title":"Adjuvant treatment for patients with FIGO stage i uterine serous carcinoma confined to the endometrium","volume":"30","author":"Nasioudis","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2026.04.004_bb0525","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ygyno.2022.09.025","article-title":"Adjuvant therapy in women with early stage uterine serous carcinoma: a multi-institutional study","volume":"167","author":"Kurnit","year":"2022","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2026.04.004_bb0535","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ygyno.2007.07.070","article-title":"A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus","volume":"107","author":"Wolfson","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.04.004_bb0561","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ygyno.2017.02.001","article-title":"Impact of adjuvant therapy on recurrence patterns in stage I uterine carcinosarcoma","volume":"145","author":"Matsuo","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.04.004_bb0540","article-title":"Patterns of adjuvant treatment and survival outcomes in stage I uterine carcinosarcoma","volume":"39","author":"Cory","year":"2022","journal-title":"Gynecol. Oncol. Rep."},{"issue":"1","key":"10.1016\/j.ygyno.2026.04.004_bb0550","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41379-019-0358-x","article-title":"HER2 testing of gynecologic carcinosarcomas: tumor stratification for potential targeted therapy","volume":"33","author":"Rottmann","year":"2020","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2026.04.004_bb0555","author":"ClinicalTrials.gov"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582601944X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582601944X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:59:03Z","timestamp":1794473943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082582601944X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":109,"alternative-id":["S009082582601944X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.04.004","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endometrial cancer: A Society of Gynecologic Oncology evidence-based review and recommendations: Part I","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}